My Expertise

Prof. Salah Abusnana

MSc (UK), PhD (UK), FRCP (UK), CCST (UK)

Director of the University of Sharjah Center for Diabetes
Deputy Chair of Clinical Science Department, UOS
Program Director for MSc in Diabetes Management, UOS
Director of Diabetes and Endocrine Center, UHS

I am a Professor of Endocrinology engaged in patient care, education, and research. I have devoted my career to the development and refinement of Diabetes management that improve the safety and efficacy of the latest available medicines and technology, specifically in patients with complex diabetes-related complications and endocrine disorders.


A Lifelong Pursuit of Excellence in Diabetes and Endocrine Care

Embarking on a journey that has spanned continents and decades, I, Prof. Salah Abusnana, have dedicated my life to advancing diabetes and endocrine care. From my foundational years in Libya to transformative experiences in the United Kingdom, and culminating in pioneering contributions in the United Arab Emirates, my path reflects a commitment to innovation, education, and compassionate healthcare.

My medical journey commenced with a degree from Al-Fatah University in Libya in 1990. Driven by a desire to broaden my expertise, I relocated to the United Kingdom in 1994, where I trained at esteemed institutions including Hammersmith Hospital, Guys and St. Thomas Hospital, and Brighton University Hospital. These formative years were marked by rigorous clinical practice and groundbreaking research, leading to the attainment of my MRCP in 1995, an MSc in Neuroendocrinology in 1996, and a Ph.D. from Imperial College London in 2001.

In 2010, I embraced an opportunity in the United Arab Emirates, joining University Hospital Sharjah as a Senior Consultant in Diabetes, Endocrinology, and Internal Medicine. Subsequently, I assumed the roles of Professor and Deputy Chair for the Clinical Science Department at the University of Sharjah. In 2011, I was honored to be appointed Medical Director of the Rashid Centre for Diabetes and Research (RCDR) where I introduced innovative services such as insulin pump therapy and weight management, establishing new standards in the region.

A significant milestone was the creation of the Master of Science in Diabetes Management at the University of Sharjah—the first program of its kind in the UAE. Conceived in 2016 and launched in 2020, this program empowers healthcare professionals with advanced expertise to combat the growing diabetes epidemic. In 2018, I founded the Sharjah Diabetes and Endocrine Center of Excellence and the Sharjah Diabetes Research Institute, integrating research with clinical care to address critical healthcare challenges.

Beyond clinical practice and research, I have been deeply engaged in global knowledge sharing, delivering keynote addresses at prestigious international conferences and collaborating with esteemed organizations such as the British Endocrine Society, the European Society of Diabetes, and the American Diabetes Association. In addition to these speaking engagements, I have had the privilege of chairing influential board meetings, contributing to strategic decision-making committees, and serving as a trusted advisor to various healthcare organizations.My efforts in advancing diabetes and endocrine care have been recognized with numerous awards for leadership, innovation, and excellence in the field. These honors reflect not only my personal dedication but also the collective achievements of the remarkable teams and communities I have been fortunate to work alongside throughout my journey.

My career is driven by a singular purpose : to improve lives through compassionate care, innovative research, and education. From the corridors of London’s leading hospitals to the healthcare institutions of the UAE, my journey underscores the power of vision, collaboration, and commitment in shaping the future of diabetes care and education.

Key Milestones:

  • 1990: Earned MBBCH from Al-Fatah University, Libya.
  • 1994: Began specialization in the UK at esteemed institutions like Hammersmith Hospital.
  • 1995-2001: Achieved MRCP, MSc, and Ph.D. with a focus on neuroendocrinology and obesity.
  • 2010: Joined University Hospital Sharjah and the University of Sharjah.
  • 2011: Appointed Medical Director of the Rashid Centre for Diabetes and Research (RCDR), UAE.
  • 2016: Envisioned the MSc in Diabetes Management at the University of Sharjah.
  • 2018: Established the Sharjah Diabetes and Endocrine Center of Excellence and Research Institute.
  • 2020: Launched the MSc program, the first of its kind in the UAE.

My Mission

I want to assist you in achieving your goal and treating the illness by providing you with an integrated care system

As a medical doctor with over 25 years of experience who treats you as an individual, I take an all-rounded Multi-Disciplinary Team MDT approach by bringing all elements of the diabetes ecosystem together, including medical devices, education, and therapeutics for you.

My vision

My vision is to revolutionize the local healthcare delivery system by dedicating my life to it

To understand the causes and consequences of diabetes, I have trained with leading scientists and physicians worldwide for years and thousands of hours. To help you regain control over your health, to impart all that I’ve learned. As a part of the centre of excellence for innovation in diabetes research, education, and clinical care, I aim to tangibly impact diabetes prevention and outcomes in the Emirates and globally.

My Goal

I strive to achieve good clinical outcomes for my patients to provide them with the best possible quality of life

My goal is to bring together researchers and healthcare professionals from a variety of related disciplines to: Lead discoveries in patient-centred research, extensive clinical trials, and basic science across affiliated hospitals and research institutes Create cutting-edge diagnostic trajectories to treat diabetes or avert its complications Find novel uses for contemporary technologies to control diabetes and enhance the Lives of persons with the condition.

My Gallery

This is a simple headline

This is a sub title

PUBLICATIONS

More than 65+ Publications !


  1. Tariq, Z., Abusnana, S., Mussa, B. M., & Zakaria, H. (2024). New insights on genetic background of major diabetic vascular complications. Diabetology & metabolic syndrome, 16(1), 243. https://doi.org/10.1186/s13098-024-01473-y
  2. Shaheen, A., Sadiya, A., Mussa, B. M., & Abusnana, S. (2024). Postprandial Glucose and Insulin Response to Meal Sequence Among Healthy UAE Adults: A Randomized Controlled Crossover Trial. Diabetes, metabolic syndrome and obesity : targets and therapy, 17, 4257–4265. https://doi.org/10.2147/DMSO.S468628
  3. Muayyad, M., Abusnana, S., Mussa, B. M., Helal, R., Abdelrahim, D. N., Abdelreheim, N. H., Al Amiri, E., Daboul, M., Al-Abadla, Z., Lessan, N., & Faris, M. E. (2024). Adherence to the Mediterranean diet and sleep quality are inter-correlated with flash glucose monitoring (FGM)-measured glycemia among children with type 1 diabetes. Journal of education and health promotion, 13, 284. https://doi.org/10.4103/jehp.jehp_1609_23
  4. Weisy, O. K. M., Kedia, R. A., Mahmoud, I., Abu Odeh, R. O., Mussa, B. M., Abusnana, S., Soliman, S. S. M., Muhammad, J. S., Hamad, M., Ghemrawi, R., & Khoder, G. (2024). Assessment of Helicobacter pyloricytotoxin-associated Gene A (Cag A) protein and its association with ferritin and vitamin B12 deficiencies among adult healthy asymptomatic residents in Sharjah, United Arab Emirates. Heliyon, 10(11), e32141. https://doi.org/10.1016/j.heliyon.2024.e32141
  5. Ramakrishnan, R. K., Srivastava, A., Rajan, R., Abusnana, S., & Mussa, B. M. (2024). Investigating the role of an immediate early gene FOS as a potential regulator of autophagic response to hypoglycemia in embryonic hypothalamic neurons. Clinical and translational science, 17(3), e13749. https://doi.org/10.1111/cts.13749
  6. Alzarooni, K. I., Abusnana, S., Zakaria, H., Hussein, A., Mussa, B. M., & Mohammed, G. (2024). Predictive factors of perinatal depression among women with gestational diabetes mellitus in the UAE: a cross-sectional clinical study. BMC pregnancy and childbirth, 24(1), 146. https://doi.org/10.1186/s12884-024-06307-3
  7. Alnimer, A., Bhamidimarri, P. M., Talaat, I. M., Alkhayaal, N., Eltayeb, A., Ali, N., Abusnana, S., Hamoudi, R., & Bendardaf, R. (2023). Association Between Expression of Vitamin D Receptor and Insulin-Like Growth Factor 1 Receptor Among Breast Cancer Patients. World journal of oncology, 14(1), 67–74. https://doi.org/10.14740/wjon1550
  8. Abusnana, S., Al Awadi, F., Aly, H., Bashier, A., Kumar Dhanwal, D., Halasa, T., Jallo, M., Medina, J., & Singhal, S. (2023). Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospective INTENSIFY study. Diabetes research and clinical practice, 196, 110183. https://doi.org/10.1016/j.diabres.2022.110183
  9. Al Ali, T., Ashfaq, A., Saheb Sharif-Askari, N., Abusnana, S., & Mussa, B. M. (2023). Investigating the Association between Diabetic Neuropathy and Vitamin D in Emirati Patients with Type 2 Diabetes Mellitus. Cells, 12(1), 198. https://doi.org/10.3390/cells12010198
  10. Zakaria, H.; Abusanana, S.; Mussa, B.M.; Al Dhaheri, A.S.; Stojanovska, L.; Mohamad, M.N.; Saleh, S.T.; Ali, H.I.; Cheikh Ismail, L. The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus. Medicina Feb 2023, 59, 287. https://doi.org/10.3390/medicina59020287
  11. Al Ali, Tahra, Alizeh Ashfaq, Narjes Saheb Sharif-Askari, Salah Abusnana, and Bashair M. Mussa. Jan 2023. “Investigating the Association between Diabetic Neuropathy and Vitamin D in Emirati Patients with Type 2 Diabetes Mellitus” Cells 12, no. 1: 198.https://doi.org/10.3390/cells12010198
  12. Hassanein M, Almansari A, Ba-Essa E, Alawadi F, F, ElBadawi H, Sahay R, K, Malik R, Abdul Ghani R, Abusnana S, Shaikh S, Zainudin S, B, Elhadd T, AL Saleh Y: Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan. Dubai Diabetes Endocrinol J 2022 Dec. doi: 10.1159/000527475
  13. Elemam NM, Talaat IM, Bayoumi FA, Zein D, Georgy R, Altamimi A, Alkhayyal N, Habbal A, Al Ali F, ElKhider A, Ahmed A, Abusnana S, Bendardaf R. Peripheral blood cell anomalies in COVID-19 patients in the United Arab Emirates: A single-centered study. Front Med (Lausanne). 2022 Dec 15;9:1072427. doi: 10.3389/fmed.2022.1072427. PMID: 36590943; PMCID: PMC9797815.
  14. Abusnana S, Al Awadi F, Aly H, Bashier A, Kumar Dhanwal D, Halasa T, Jallo M, Medina J, Singhal S. Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospective INTENSIFY study. Diabetes Res Clin Pract. 2022 Nov 24:110183. doi: 10.1016/j.diabres.2022.110183. Epub ahead of print. PMID: 36436550.
  15. Mussa BM, Venkatachalam T, Srivastava A, Al-Habshi A, Abdelgadir E, Bashier A, Al Awadi F, Hafidh K, Hamoudi R, Abusnana S. Identification of novel differentially expressed genes in type 1 diabetes mellitus complications using transcriptomic profiling of UAE patients: a multicenter study. Sci Rep. 2022 Sep 29;12(1):16316. doi: 10.1038/s41598-022-18997-w. PMID: 36175575; PMCID: PMC9523055.
  16. Srivastava A, Mussa BM, Abusnana S. Increased expression of BDNF and inflammatory biomarkers in type 2 diabetes-related claustrophobia: A case report. Advances in Biomedical and Health Sciences. 2022 Jul 1;1(3):175.
  17. Zakaria H, Abusanana S, Mussa BM, Al Dhaheri AS, Stojanovska L, Mohamad MN, Saleh ST, Ali HI, Cheikh Ismail L. The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus. Medicina. 2023; 59(2):287. https://doi.org/10.3390/medicina59020287
  18. Mussa BM, Srivastava A, Al-Habshi A, Mohammed AK, Halwani R, Abusnana S. Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy. Diabetes Metab Syndr Obes. 2021;14:3389-3397 2021 July https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323777/
  19. Roberta Giordo, Yusra M. A. Ahmed1, Hilda Allam, Salah Abusnana, Lucia Pappalardo, Gheyath K. Nasrallah, Arduino Aleksander Mangoni and Gianfranco Pintus EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress 2021 May 19.https://www.frontiersin.org/articles/10.3389/fcell.2021.683594/full
  20. Nawar R, Ibrahim E, Abusnana S, Al Awadi F, Al Hammadi F, H, Farghaly M, Fiad T, M, Aly H, Aly Mohamed Y, Ben Serghin Z: “Understanding the Gaps in Obesity Management in the UAE: Perceptions, Barriers, and Attitudes”. Dubai Diabetes Endocrinol J 2021;27:37-49. doi: 10.1159/000514359 2021 April 7. https://www.karger.com/Article/FullText/514359
  21. Al Zoubi, Y.; Mussa, B.M.;Srivastava, A.; Mohammed, A.K.;Abdelgadir, E.; Bashier, A.; Awadi,F.A.; Abusnana, S. Differential Expression of Inflammatory Markers in Hypoglycemia Unawareness Associated with Type 1 Diabetes: A Case Report. 2020 December 25. https://www.mdpi.com/2076-3425/11/1/17
  22. Riyad Bendardaf ,Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif-Askari,Salman Yousuf Guraya ,Sawsan A AlMadhi,Salah Abusnana, Incidence and Clinicopathological Features of Breast Cancer in the Northern Emirates Experience from Sharjah Breast Care Center 2020 Oct 27. https://www.dovepress.com/incidence-and-clinicopathological-features-of-breast-cancer-in-the-nor-peer-reviewed-fulltext-article-IJWH
  23. Asma M. Fikri1,Rosemary Smyth, Vijay Kumar, Zainab Al‑Abadla, Salahedeen Abusnana & Michael R. Munday, Pre‑diagnostic biomarkers of type 2 diabetes identified in the UAE’s obese national population using targeted metabolomics https://doi.org/10.1038/s41598-020-73384-7 2020 Oct 19. https://www.nature.com/articles/s41598-020-73384-7
  24. Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Bushra Mdkhana, Saba Al Heialy,, Elaref Ratemi, Malak Alghamdi, Salah Abusnana, Tarek Kashour, Qutayba Hamid, and Rabih Halwani corresponding author, Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue 2020 Aug 17 https://link.springer.com/article/10.1007/s00204-020-02869-1
  25. Noura Alkhayyal ,Iman Talaat ,Arya Vinodnadat , Azzam Maghazachi , Salah Abusnana , Kari Syrjänen , Riyad Bendardaf , Correlation of Insulin-like Growth Factor 1 Receptor Expression With Different Molecular Subtypes of Breast Cancer in the UAE, March 2020
  26. Fatheya Alawadi, Salah Abusnana, Bachar Afandi, Khaled M. Aldahmani, Omniyat Alhajeri, Khaled Aljaberi, Juma Alkaabi, Abdulrazzaq Almadani, Alaaeldin Bashier, Salem A. Beshyah, Buthaina bin Belaila, Mohammad Fargaly, Muhammad H. Farooqi, Khadija Hafidh, Mohamed Hassanein, Ahmed Hassoun, Abdul Jabbar, Iyad Ksseiry, Huda E. Mustafa, Hussein Saadi, Sara Suliman, Emirates Diabetes Society Consensus Guidelines for the Management of Type 2 Diabetes Mellitus – 2020 Feb 19
  27. Fatemeh Saheb SharifAskari ,Narjes Saheb Sharif-Askari ,Rabih Halwani ,Salah Abusnana, Rifat Hamoudi, Nabil Sulaiman. Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals. Diabetes, Metabolic Syndromeawards and Obesity: Targets and Therapy 2020:13 1599–1607
  28. Narjes Saheb Sharif-Askari,Hanan Abdulgader Sharif,Fatemeh Saheb Sharif-Askari,Qutayba Hamid, Salah Abusnana, Rifat Hamoudi. Association between body mass index and asthma severity in Arab pediatric population: A retrospective study. December 27 2019
  29. Rifat Hamoudi, Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Salah Abusnana, HayatAljaibeji, JalalTaneera,Nabil Sulaiman. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates Nov 2019
  30. Bashair M Mussa, Mia Schauman, Vijay Kumar, Sijomol Skaria, Salah Abusnana 2019 . Personalized intervention to improve stress and sleep patterns for glycemic control and weight management in obese Emirati patients with type 2 diabetes: a randomized controlled clinical trial 28 June 2019 Volume 2019:12 Pages 991—99
  31. Abusnana S, Beshyah SA, Al-Mutawa N, Tahhan R, Jallo M, Arora R, Aly H, Singhal S. 2019. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study. Sultan Qaboos Univ Med J. 2018 Nov;18(4):e447-e454.
  32. Aldawi N, Darwiche G, Abusnana S, Elbagir M, Elgzyri T.2019. Initial increase in glucose variability during Ramadan fasting in non-insulin-treated patients with diabetes type 2 using continuous glucose monitoring. Libyan J Med. 2019 Dec;14(1):1535747.
  33. Saber-Ayad M, Manzoor S, El Serafi A, Mahmoud I, Hammoudeh S, Rani A, Abusnana S, Sulaiman N.2018. The FTO rs9939609 “A” allele is associated with impaired fasting glucose and insulin resistance in Emirati population. 2019 Jan 10;681:93-98.
  34. Abusnana S, Fargaly M, Alfardan SH, Al Hammadi FH, Bashier A, Kaddaha G, McGowan B, Nawar R, Sadiya A.2018. Clinical Practice Recommendations for the Management of Obesity in the United Arab Emirates. Obes Facts. 2018 Nov; 11(5): 413–428.
  35. Mussa BM, Hamoudi RA, Abusnana S2018 . Association Trends Between Antihypertensive Drug Therapies and Diastolic Hypotension in Emirati Patients with Type 2 Diabetes: A Single-Center Retrospective Longitudinal Study. Diabetes Ther. 2018 Oct;9(5):1853-1868.
  36. Sulaiman N, Albadawi S, Abusnana S, Mairghani M, Hussein A, Al Awadi F, Madani A, Zimmet P, Shaw J.2018. High prevalence of diabetes among migrants in the United Arab Emirates using a cross-sectional survey. Sci Rep. 2018 May 1;8(1):6862.
  37. Sulaiman N, Mahmoud I, Hussein A, Elbadawi S, Abusnana S, Zimmet P, Shaw J.2018. Diabetes risk score in the United Arab Emirates: a screening tool for the early detection of type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2018 Mar 29;6(1):e000489
  38. Saber-Ayad M, Manzoor S, El-Serafi A, Mahmoud I, Abusnana S, Sulaiman N.2018. Statin-induced myopathy SLCO1B1 521T > C is associated with prediabetes, high body mass index and normal lipid profile in Emirati population. Diabetes Res Clin Pract. 2018 May;139:272-277
  39. Linjawi S, Lee BW, Tabak Ö, Lövdahl S, Werther S, Abusnana S. 2018. A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal-Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes. Diabetes Ther. 2018 Feb;9(1):1-11.
  40. Sulaiman N, Elbadawi S, Hussein A, Abusnana S, Madani A, Mairghani M, Alawadi F, Sulaiman A, Zimmet P, Huse O, Shaw J, Peeters A. 2017. Prevalence of overweight and obesity in United Arab Emirates Expatriates: the UAE National Diabetes and Lifestyle Study. Diabetol Metab Syndr. 2017 Nov 2;9:88.
  41. Al-Dmour JA, Sagahyroon A, Al-Ali AR, Abusnana S.2017. A fuzzy logic-based warning system for patients classification. Health Informatics J. 2017 Nov 1:1460458217735674
  42. Emral R, Pathan F, Cortés CAY, El-Hefnawy MH, Goh SY, Gómez AM, Murphy A, Abusnana S, Rudijanto A, Jain A, Ma Z, Mirasol R; IO HAT Investigator Group.2017. Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey on 7289 patients from nine countries.. Diabetes Res Clin Pract. 2017 Dec;134:17-28
  43. Sadiya A, Abdi S, Abusnana S.2016. Lifestyle Intervention for Weight Loss: a group-based program for Emiratis in Ajman, United Arab Emirates. Diabetes Metab Syndr Obes. 2016 Mar 18;9:101-8.
  44. Sadiya, A. Ahmed, S. M., Skaria, S., Abusnana, S. 2014. Vitamin D Status and Its Relationship with Metabolic Markers in Persons with Obesity and Type 2 Diabetes in the UAE: A Cross-Sectional Study. Journal of Diabetes Research 2014, 1-7.
  45. Farajallah, A., Ahmed, A., Abdullah, N., Andrew, P., Abusnana, S. 2014. The Relationship between Type 2 Diabetes and Total Ghrelin Level in a Population Sample in the United Arab Emirates, IOSR 4, 01-08.
  46. Almousa, A., Thomas, M., Siddieg, H., Varghese, S., Abusnana, S. 2013. The Glycemic Index of Traditional Types of Bread in UAE. Journal of Nutrition and Food Science 3, 1-6.
  47. Abusnana, M.D. Turton, M. Rossi, C.J. Small, C.M. Edwards, I. Gunn, M.M. Heath, D.G. Morgan, A.P. Goldstone, D. Sunter, M.S. Kim, K. Meeran, M.A. Ghatei, a S.R. Bloom, and D. O’Shea, Corticotropin releasing factor acts independently of CRF1 and CRF2 receptors within the paraventricular nucleus to reduce feeding. J. Endocrinology 156 (1998) P183.
  48. Abusnana, S.E. Morrssey, A-M. Cowell, and J.F. Laycock. Purified prolactin influences cardiovascular and renal function in Brattleboro rats with hereditary diabetes. J. Endocrinology 152 (1997) P181.
  49. Abusnana, B. McGowan, J. Powrie, K Muralidhara, P. Carroll.Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 19 cases investigated in a single endocrine centre. NET Seb 2009.
  50. Edwards, C. M., Abusnana, S., Sunter, D., Murphy, K. G., Ghatei, M. A., & Bloom, S. R. 1999, “The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin”, Endocrinol., vol. 160, no. 3, pp. R7-12.
  51. Kim, M. S., Rossi, Abusnana, S., M., Sunter, D., Morgan, D. G., Small, C. J., Edwards, C. M., Heath, M. M., Stanley, S. A., Seal, L. J., Bhatti, J. R., Smith, D. M., Ghatei, M. A., & Bloom, S. R. 2000, “Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone”, Diabetes, vol. 49,no. 2, pp. 177-182.
  52. Morgan, D. G., Small, C. J., Abusnana, S., Turton, M., Gunn, I., Heath, M., Rossi, M., Goldstone, A. P., O’Shea, D., Meeran, K., Ghatei, M., Smith, D. M., & Bloom, S. 1998, “The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism”, Pept. , vol. 75-76, pp. 377-382.
  53. Meeran, K., O’Shea, D., Edwards, C. M., Turton, M. D., Heath, M. M., Gunn, I., Abusnana, S., Rossi, M., Small, C. J., Goldstone, A. P., Taylor, G. M., Sunter, D., Steere, J., Choi, S. J., Ghatei, M. A., & Bloom, S. R. 1999, “Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat”, Endocrinology, vol. 140,no. 1, pp. 244-250.
  54. Edwards, C. M., Abbott, C. R., Sunter, D., Kim, M., Dakin, C. L., Murphy, K. G., Abusnana, S., Taheri, S., Rossi, M., & Bloom, S. R. 2000, “Coc”, Brain Res., vol. 866,no. 1-2, pp. 128-134.
  55. Rossi, M., Kim, M. S., Morgan, D. G., Small, C. J., Edwards, C. M., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A., Smith, D. M., Yagaloff, K., Ghatei, M. A., & Bloom, S. R. 1998, “A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo”, Endocrinology, vol. 139,no. 10, pp. 4428-4431.
  56. Kim, M. S., Small, C. J., Stanley, S. A., Morgan, D. G., Seal, L. J., Kong, W. M., Edwards, C. M., Abusnana, S., Sunter, D., Ghatei, M. A., & Bloom, S. R. 2000, The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin, Clin.Invest, vol. 105,no. 7, pp. 1005-101.
  57. Sarah Abdi, Amina Sadiya, Samia Ali, Shiby Varghese, Salah Abusnana, 2015. Behavioral Lifestyle Intervention Study (BLIS) in patients with type 2 diabetes in the United Arab Emirates: A randomized controlled trial. BMC Nutrition.
  58. Alaaeldin M. K. Bashier Azza Abdulaziz Khalifa Bin Hussain· Elamin Ibrahim Elamin Abdelgadir· Ahmed Tarig Eltinay· Puja Thadani· Mohamed Elhassan Abdalla· Salah Abusnana Liraglutide effect in reducing HbA1c and weight in Arab population with type2 diabetes, a prospective observational trial Dec 2015 · Journal of Diabetes and Metabolic Disorder.
  59. Salah Abusnana Sami T Azar· Akram Echtay· W M Wan Bebakar· Sumayya Al Araj· Abdelkrim Berrah· Mahommed Omar· Abhay Mutha· Karen Tornøe· Margit Kaltoft· Naim Shehadeh Efficacy and safety of liraglutide versus sulphonylurea, both in combination with metformin, during Ramadan in subjects with type 2 diabetes Conference Paper · Oct 2015
  60. Salah Abusnana Sarah Abdi· Brigette Tagure· Murtada Elbagir· Almantas Maleckas Oct 2015 · Bariatric surgery outcomes: A single-center study in the United Arab Emirates Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.
  61. New and Advanced Therapy in Diabetes Management Salah Abusnana Conference Paper · Mar 2015.
  62. Amena Sadiya Solafa M Ahmed·Martin Carlsson· Yohannes Tesfa ·Mary George · Samia H Ali· Hisham H Siddieg · Salah Abusnana, Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial Mar 2015 · Clinical nutrition (Edinburgh, Scotland).
  63. Basjhair Mussa Yaqeen Jomma· Salah Abusnana, Prevalence of hypertension and obesity among Emirati diabetic patients attending Rashid Centre for Diabetes and Research Conference Paper · Feb 2015.
  64. Maria Reynolds Fatma Haroon· Salah Abusnana Insulin Injection Technique Survey Results, The UAE- Rashid Centre for Diabetes and Research [Show abstract] Full-text · Conference Paper ·
  65. Bashair Mussa Mia Schauman· Vijay Kumar· Sijomol Skaria· Salah Abusnana. Evaluation of Stress in Emirati Patients Using Firstbeat Technology Conference Paper · Feb 2015.
  66. Management of T2DM in Special Patient PopulationsSalah Abusnana Conference Paper · Dec 2014
  67. Hypertension target in diabetes, revisiting the evidence, Salah Abusnana, Iben Sina Juornal, Dec 2012.
  68. M.B. Edwards, Caroline R. Abbott, David Sunter, Min-Seon Kim,Catherine L. Dakin, Kevin G. Murphy, Salah Abusnana, Shahrad Taheri,Michela Rossi, Stephen R. Bloom Cocaine-and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat ICSM Endocrine Unit, Hammersmith Hospital, March 2000
  69. Nabil Sulaiman,Salah Albadawi, Salah Abusnana, Mahmoud Fikri, Abdulrazzag Madani, Maisoon Mairghani, Fatheya Alawadi,Paul Zimmet, Andjonathan Shaw Novel approach to systematic random sampling in population surveys: Lessons from the United Arab Emirates National Diabetes Study
  70. A Sadiya, SM Ahmed, M Carlsson, Y Tesfa, M George, SH Ali, HH Siddieg and S Abusnana (UAEDIAB) 2015 Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial European Journal of Clinical Nutrition (2015)

MY CV

Appoinment

    Contact Info

    Lorem ipsum dolor sit amete nilher, consectetured adipiscing elit. Nullam feugiat faucibus nibh gravida convallis massa sed fringilla. Pellentesque habitant dolor morbi tristique senectus et netus et malesuada fames ac turpis egestas.

    Phone Number : +971505605029

    Email Address: zuira.tariq@gmail.com

    Skype ID : uremail@gmail.com

    Permanent Address :

    PRESS RELEASE

    A title

    Image Box text

    معمل لفحص »اليود« مطلع العام المُقبل وتحليل ١٠٠ ألف عيّنة يومياً

    A laboratory to test “iodine” early next year and analyze 100,000 samples per day

    باحثومثابر،ُيعانقالامتياز،وُيسجلتفوقهالعلميبمراكمةالنجاحات وحصاد ا􏰀نجازات، يؤمن بأن الصحة حصن يؤمن المجتمع من مخاطر العلل وا􏰁مــراض،ويضمنسلامته،لذايوظفخبراتهالواسعةالتيحصلهاعبر عمله في أعرق المستشفيات البريطانية، 􏰀جراء بحوث علم ّية كفيلة بتوفير الحلول العلاجية والسبل الوقائيةA persistent researcher, embracing excellence, and recording his scientific excellence by accumulating successes and reaping achievements. He believes that health is a fortress that secures society from the dangers of ailments and diseases, and guarantees its safety. Therefore, he employs his extensive experience that he gained through his work in the most prestigious British hospitals, 7. to conduct scientific research capable of providing Curative and preventive solutions
    Download PDF

    GAED Awards 2023

    GAED 2023 MEDAL AWARDS

    Patient Testimonials